Skip to main content
OpenTrials

Clinical trial condition

Female Urogenital Diseases

Explore clinical trials studying Female Urogenital Diseases. Study availability and eligibility vary by location and protocol.

22,034 public trials 3,765 recruiting studies
Refine in advanced search Browse all conditions

Female Urogenital Diseases trial results

Recruiting

cfDNA Assay Prospective Observational Validation for Early Cancer Detection and Minimal Residual Disease

NCT05366881

Conditions
Adnexal Diseases, Bladder Cancer, Blood Protein Disorders, +96 more
Locations
  • City of Hope Duarte, California, United States
  • Miami Cancer Institute Miami, Florida, United States
  • North Georgia Health System Gainesville, Georgia, United States
  • Baptist Floyd New Albany, Indiana, United States
View all 17 locations
View Trial Details
Recruiting

Lymphedema After Urologic Surgery

NCT05264337

Conditions
Endocrine Gland Neoplasms, Endocrine System Diseases, Female Urogenital Diseases, +24 more
Locations
  • Sahlgrenska University Hospital Gothenburg, Sweden
  • Örebro University Hospital Örebro, Sweden
View Trial Details
Recruiting

Risk of Recurrent Urethral Stricture After Treatment With Paclitaxel-Coated Dilatation Balloon (Optilume) Compared With Non-coated Dilatation Balloon

NCT06795074

Conditions
Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Male Urogenital Diseases, +5 more
Locations
  • Sahlgrenska University Hospital Gothenburg, Sweden
  • Skåne University Hospital Malmö, Sweden
  • Örebro University Hospital Örebro, Sweden
  • Karolinska University Hospital Stockholm, Sweden
View Trial Details
Recruiting

A Study of HC-7366 in Combination With Belzutifan (WELIREG™) in Patients With Renal Cell Carcinoma

NCT06234605

Conditions
Adenocarcinoma, Carcinoma, Carcinoma, Renal Cell, +18 more
Locations
  • University of Arizona Cancer Center Tucson, Arizona, United States
  • University of California San Diego Moores Cancer Center La Jolla, California, United States
  • Cedars-Sinai Medical Center Los Angeles, California, United States
  • University of Colorado Anschutz Medical Campus Aurora, Colorado, United States
View all 20 locations
View Trial Details

Related conditions